Irisin is a recently discovered adipomyokine that was initially suggested as a browning factor of white adipose tissue, orchestrating the beneficial effects of exercise in metabolism, and, thus, raising high expectations as a potential therapeutic agent against metabolic diseases [14]. Here, FNDC5 is linked to Other metabolic disease.